Table I.
H0 groupb | H1 groupb | H4 groupb | P-value for ANOVA | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. | tr/min | m/z | Adduct | Metabolite | Associated pathway | n=10 | n=10 | n=10 | VIPc | H1 & H0 | H4 & H0 | H4 & H1 | |
ESI | |||||||||||||
(+) | |||||||||||||
1 | 1.13 | 118.086 | M+H | Valinea | Valine, leucine and isoleucine biosynthesis | 0.0523±0-.0082 | 0.0650±0.0108 | 0.1203±0.0236 | 1.36 | 0.026 | P<0.01 | P<0.01 | |
2 | 1.16 | 204.123 | M+H | Acetylcarnitine | Fatty acid transportation | 0.0965±0.0109 | 0.0743±0.0106 | 0.0425±0.0090 | 1.21 | P<0.01 | P<0.01 | P<0.01 | |
3 | 1.17 | 150.058 | M+H | Methioninea | Cysteine and methionine metabolism | 0.0401±0.0048 | 0.0479±0.0100 | 0.0954±0.0181 | 1.24 | 0.117 | P<0.01 | P<0.01 | |
4 | 1.63 | 182.081 | M+H | Tyrosine | Tyrosine metabolism | 0.0448±0.0080 | 0.0748±0.0139 | 0.1208±0.0292 | 1.39 | P<0.01 | P<0.01 | 0.002 | |
5 | 1.80 | 132.102 | M+H | Isoleucine | Valine, leucine and isoleucine biosynthesis | 0.2824±0.0432 | 0.4661±0.1708 | 0.6779±0.1256 | 3.09 | 0.023 | P<0.01 | 0.017 | |
6 | 3.64 | 166.086 | M+H | Phenylalaninea | Phenylalanine metabolism | 0.1812±0.0179 | 0.2628±0.0472 | 0.3334±0.0413 | 2.01 | 0.001 | P<0.01 | 0.007 | |
7 | 14.62 | 494.325 | M+H | LysoPC(16:1) | Glycerophospholipid metabolism | 0.0488±0.0085 | 0.1010±0.0244 | 0.0672±0.0179 | 1.09 | P<0.01 | 0.032 | 0.008 | |
8 | 15.16 | 520.341 | M+H | LysoPC(18:2) | Glycerophospholipid metabolism | 1.4183±0.2117 | 2.2970±0.3396 | 1.5134±0.2553 | 4.84 | P<0.01 | 1.000 | P<0.01 | |
9 | 15.20 | 568.341 | M+H | LysoPC(22:6) | Glycerophospholipid metabolism | 0.2987±0.0414 | 0.4279±0.1073 | 0.2297±0.0420 | 2.23 | 0.012 | 0.005 | P<0.01 | |
10 | 15.22 | 544.341 | M+H | LysoPC(20:4) | Glycerophospholipid metabolism | 0.4145±0.0396 | 0.7173±0.2747 | 0.4391±0.1241 | 2.47 | 0.019 | 0.907 | 0.035 | |
11 | 15.44 | 424.343 | M+H | Linoelaidylcarnitine | Fatty acid transportation | 0.0242±0.0061 | 0.0633±0.0257 | 0.0529±0.0161 | 1.10 | 0.002 | 0.001 | 0.633 | |
12 | 15.77 | 546.356 | M+H | LysoPC(20:3) | Glycerophospholipid metabolism | 0.0910±0.0171 | 0.2249±0.0473 | 0.1192±0.0485 | 1.84 | P<0.01 | 0.281 | P<0.01 | |
13 | 15.91 | 400.343 | M+H | Palmitoylcarnitine | Fatty acid transportation | 0.0632±0.0113 | 0.0864±0.0211 | 0.1100±0.0151 | 1.05 | 0.011 | P<0.01 | 0.010 | |
14 | 16.14 | 522.357 | M+H | LysoPC(18:1) | Glycerophospholipid metabolism | 0.8837±0.1314 | 1.4495±0.3031 | 1.0217±0.2578 | 3.50 | P<0.01 | 0.380 | 0.010 | |
15 | 16.24 | 426.359 | M+H | Octadecenoylcarnitine | Fatty acid transportation | 0.0635±0.0086 | 0.1158±0.0222 | 0.1484±0.0194 | 1.48 | P<0.01 | P<0.01 | 0.008 | |
ESI | |||||||||||||
(−) | |||||||||||||
1 | 0.74 | 124.008 | M-H | Taurine | Taurine and hypotaurine metabolism | 0.3305±0.0689 | 0.3886±0.0563 | 0.6527±0.0923 | 1.10 | 0.272 | P<0.01 | P<0.01 | |
2 | 0.82 | 133.015 | M-H | Malate | Citrate cycle (TCA cycle) | 0.2442±0.1123 | 0.4746±0.0960 | 0.1731±0.0642 | 1.53 | P<0.01 | 0.297 | P<0.01 | |
3 | 1.20 | 167.021 | M-H | Uric acid | Purine metabolism | 0.4654±0.0871 | 1.2867±0.1555 | 0.6374±0.1670 | 2.72 | P<0.01 | 0.033 | P<0.01 | |
4 | 1.28 | 191.020 | M-H | Citratea | Citrate cycle (TCA cycle) | 0.7793±0.2188 | 1.7729±0.2274 | 1.1371±0.2382 | 1.83 | P<0.01` | 0.005 | P<0.01 | |
5 | 1.58 | 117.019 | M-H | Succinatea | Citrate cycle (TCA cycle) | 0.1866±0.1333 | 1.1098±0.2954 | 0.1141±0.0424 | 3.16 | P<0.01 | 0.324 | P<0.01 | |
6 | 16.51 | 319.229 | M-H | 15-HETE | Arachidonic acid metabolism | 2.1342±0.6468 | 3.0665±0.5586 | 2.0695±1.0005 | 2.40 | 0.009 | 0.997 | 0.044 | |
7 | 19.33 | 303.233 | M-H | Arachidonic acida | Arachidonic acid metabolism | 0.5118±0.0825 | 0.7511±0.0553 | 0.7187±0.1332 | 1.41 | P<0.01 | P<0.01 | 1.000 | |
8 | 19.50 | 279.233 | M-H | Linoleic acida | Linoleic acid metabolism | 0.3468±0.0589 | 0.8998±0.2997 | 0.5230±0.1105 | 1.46 | 0.001 | 0.002 | 0.009 | |
9 | 20.23 | 255.233 | M-H | Palmitic acida | Fatty acid metabolism | 0.1555±0.0547 | 0.4895±0.1369 | 0.2829±0.0701 | 1.12 | P<0.01 | 0.016 | P<0.01 | |
10 | 20.47 | 281.249 | M-H | Oleic acida | Fatty acid metabolism | 0.2162±0.0927 | 0.9256±0.3168 | 0.4428±0.1319 | 1.70 | P<0.01 | 0.001 | 0.002 |
Metabolites validated by reference standards.
Data are presented as the mean ± standard deviation.
VIP was obtained from partial least squares-discriminant analysis with a threshold of 1.0. 15-HETE, 15-hydroxyeicosatetraenoic acid; ANOVA, analysis of variance; TCA, tricarboxylic acid; VIP, variable importance in the projection; ESI+, positive ion mode; ESI-, negative ion mode.